These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 24148151
1. Design, synthesis and bioevaluation of novel N-substituted-3,5-bis(arylidene)-4-piperidone derivatives as cytotoxic and antitumor agents with fluorescent properties. Sun J, Zhang S, Yu C, Hou G, Zhang X, Li K, Zhao F. Chem Biol Drug Des; 2014 Apr; 83(4):392-400. PubMed ID: 24148151 [Abstract] [Full Text] [Related]
2. Synthesis, antitumor activity evaluation of some new N-aroyl-α,β-unsaturated piperidones with fluorescence. Sun J, Wang S, Li H, Jiang W, Hou G, Zhao F, Cong W. J Enzyme Inhib Med Chem; 2016 Apr; 31(3):495-502. PubMed ID: 26382011 [Abstract] [Full Text] [Related]
3. Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds. Das U, Alcorn J, Shrivastav A, Sharma RK, De Clercq E, Balzarini J, Dimmock JR. Eur J Med Chem; 2007 Jan; 42(1):71-80. PubMed ID: 16996657 [Abstract] [Full Text] [Related]
4. Design, cytotoxic and fluorescent properties of novel N-phosphorylalkyl substituted E,E-3,5-bis(arylidene)piperid-4-ones. Makarov MV, Rybalkina EY, Röschenthaler GV, Short KW, Timofeeva TV, Odinets IL. Eur J Med Chem; 2009 May; 44(5):2135-44. PubMed ID: 19046794 [Abstract] [Full Text] [Related]
7. Evaluation of some N-acyl analogues of 3,5-bis(arylidene)-4-piperidones for cytotoxic activity. Dimmock JR, Arora VK, Duffy MJ, Reid RS, Allen TM, Kao GY. Drug Des Discov; 1992 Jul; 8(4):291-9. PubMed ID: 1445994 [Abstract] [Full Text] [Related]
8. Novel 3,5-bis(arylidene)-4-piperidone dimers: potent cytotoxins against colon cancer cells. Das S, Das U, Michel D, Gorecki DK, Dimmock JR. Eur J Med Chem; 2013 Jun; 64():321-8. PubMed ID: 23644215 [Abstract] [Full Text] [Related]
9. Synthesis of N-substituted 3,5-bis(arylidene)-4-piperidones with high antitumor and antioxidant activity. Kálai T, Kuppusamy ML, Balog M, Selvendiran K, Rivera BK, Kuppusamy P, Hideg K. J Med Chem; 2011 Aug 11; 54(15):5414-21. PubMed ID: 21702507 [Abstract] [Full Text] [Related]
10. Structure-cytotoxicity relationship in a series of N-phosphorus substituted E,E-3,5-bis(3-pyridinylmethylene)- and E,E-3,5-bis(4-pyridinylmethylene)piperid-4-ones. Leonova ES, Makarov MV, Rybalkina EY, Nayani SL, Tongwa P, Fonari A, Timofeeva TV, Odinets IL. Eur J Med Chem; 2010 Dec 11; 45(12):5926-34. PubMed ID: 21035234 [Abstract] [Full Text] [Related]
11. Synthesis and evaluation of anticancer and antiobesity activity of 1-ethoxy carbonyl-3,5-bis (3'-indolyl methylene)-4-pyperidone analogs. Buduma K, Chinde S, Dommati AK, Sharma P, Shukla A, Srinivas KVNS, Arigari NK, Khan F, Tiwari AK, Grover P, Jonnala KK. Bioorg Med Chem Lett; 2016 Mar 15; 26(6):1633-1638. PubMed ID: 26873414 [Abstract] [Full Text] [Related]
12. Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo. Li N, Xin WY, Yao BR, Wang CH, Cong W, Zhao F, Li HJ, Hou Y, Meng QG, Hou GG. Eur J Med Chem; 2018 Mar 10; 147():21-33. PubMed ID: 29421568 [Abstract] [Full Text] [Related]
13. Conjugates of 3,5-Bis(arylidene)-4-piperidone and Sesquiterpene Lactones Have an Antitumor Effect via Resetting the Metabolic Phenotype of Cancer Cells. Neganova ME, Aleksandrova YR, Sharova EV, Smirnova EV, Artyushin OI, Nikolaeva NS, Semakov AV, Schagina IA, Akylbekov N, Kurmanbayev R, Orynbekov D, Brel VK. Molecules; 2024 Jun 11; 29(12):. PubMed ID: 38930831 [Abstract] [Full Text] [Related]
14. Synthesis and anticancer evaluation of furfurylidene 4-piperidone analogs. Jadhav RL, Magdum CS, Patil MV. Arch Pharm (Weinheim); 2014 Jun 11; 347(6):407-14. PubMed ID: 24623392 [Abstract] [Full Text] [Related]
15. Tumour-specific cytotoxicity and structure-activity relationships of novel 1-[3-(2-methoxyethylthio)propionyl]-3,5-bis(benzylidene)-4-piperidones. Hossain M, Das U, Umemura N, Sakagami H, Balzarini J, De Clercq E, Kawase M, Dimmock JR. Bioorg Med Chem; 2016 May 15; 24(10):2206-14. PubMed ID: 27073056 [Abstract] [Full Text] [Related]
16. Design, synthesis, and structure-activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents. Ma J, Chen D, Lu K, Wang L, Han X, Zhao Y, Gong P. Eur J Med Chem; 2014 Oct 30; 86():257-69. PubMed ID: 25171780 [Abstract] [Full Text] [Related]
17. Synthesis, characterization and structure-activity relationship of novel N-phosphorylated E,E-3,5-bis(thienylidene)piperid-4-ones. Makarov MV, Leonova ES, Rybalkina EY, Tongwa P, Khrustalev VN, Timofeeva TV, Odinets IL. Eur J Med Chem; 2010 Mar 30; 45(3):992-1000. PubMed ID: 19969398 [Abstract] [Full Text] [Related]
18. Synthesis, anticancer, and antibacterial activities of piplartine derivatives on cell cycle regulation and growth inhibition. Kumar JU, Shankaraiah G, Kumar RS, Pitke VV, Rao GT, Poornima B, Babu KS, Sreedhar AS. J Asian Nat Prod Res; 2013 Mar 30; 15(6):658-69. PubMed ID: 23668860 [Abstract] [Full Text] [Related]
19. Design and synthesis of novel 2'-hydroxy group substituted 2-pyridone derivatives as anticancer agents. Lv Z, Zhang Y, Zhang M, Chen H, Sun Z, Geng D, Niu C, Li K. Eur J Med Chem; 2013 Sep 30; 67():447-53. PubMed ID: 23920246 [Abstract] [Full Text] [Related]
20. Cytotoxic evaluation of some N-acyl and N-acyloxy analogues of 3,5-bis(arylidene)-4-piperidones. Dimmock JR, Arora VK, Chen M, Allen TM, Kao GY. Drug Des Discov; 1994 Jul 30; 12(1):19-28. PubMed ID: 7578805 [Abstract] [Full Text] [Related] Page: [Next] [New Search]